Recurrent Esophageal Cancer Terminated Phase 1 / 2 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0028797 (Recurrent Esophageal Cancer)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00064259A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction CancerTreatment